| Name | {(3aS,5aR,8aR,8bS)-2,2,7,7-Tetrakis[(2H3)methyl]tetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl}methyl sulfamate | 
|---|---|
| Synonyms | {(3aS,5aR,8aR,8bS)-2,2,7,7-Tetrakis[(2H3)methyl]tetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl}methyl sulfamate | 
| Description | Topiramate D12 (McN 4853 D12) is a deuterium labeled Topiramate. Topiramate is a broad-spectrum antiepileptic agent. Topiramate is a GluR5 receptor antagonist. Topiramate produces its antiepileptic effects through enhancement of GABAergic activity, inhibition of kainate/AMPA receptors, inhibition of voltage-sensitive sodium and calcium channels, increases in potassium conductance, and inhibition of carbonic anhydrase[1][2][3]. | 
|---|---|
| Related Catalog | |
| Target | GluR5 receptor[1]; GABAergic[2]; Kainate/AMPA[2]; Sodium channel[2]; Calcium channel[2]; Potassium channel[2]; Carbonic anhydrase[2] | 
| References | 
| Density | 1.3±0.1 g/cm3 | 
|---|---|
| Boiling Point | 438.7±55.0 °C at 760 mmHg | 
| Molecular Formula | C12H9D12NO8S | 
| Molecular Weight | 351.436 | 
| Flash Point | 219.1±31.5 °C | 
| Exact Mass | 351.174103 | 
| LogP | 2.97 | 
| Vapour Pressure | 0.0±1.1 mmHg at 25°C | 
| Index of Refraction | 1.497 | 
| Symbol |       GHS02, GHS06, GHS08 | 
|---|---|
| Signal Word | Danger | 
| Hazard Statements | H225-H301 + H311 + H331-H370 | 
| Precautionary Statements | P210-P260-P280-P301 + P310-P311 | 
| RIDADR | UN1230 - class 3 - PG 2 - Methanol, solution |